Profile for Abaxis, Inc (ABAX)

Symbol:

Profile for ABAXIS Inc. (ABAX)

After Hours: $ 14.31

0.00 (0.00%)

Volume: 713

4:23 PM EDT Oct 10, 2008

Business Description:
The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

Address:

3240 Whipple Road, Union City, CA 94587

Telephone:

(510) 675-6500

Website:

www.abaxis.com

Facsimile:

(510) 441-6150

Email:

investors@abaxis.com

Details

CEO:

Clinton H. Severson

Employees:

321

Market Cap:

311.7 m

Issue Type:

Common Stock

Auditor:

Burr, Pilger & Mayer LLP

Last Audit:

Unqualified

Indices:

Diagnostic Substances, Russell 2000, S&P 1000 Health Care Equipment Index, S&P 1500 Health Care Equipment Index, S&P 600 Health Care Equipment Index, S&P SmallCap

Industry Classifications

Sector:

Healthcare

CIK:

0000881890

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Diagnostic Substances (516)

SIC:

In Vitro And In Vivo Diagnostic Substances (2835) , Electromedical And Electrotherapeutic Apparatus (3845) , Medical, Dental, And Hospital Equipment And Supplies (5047) , Commercial Physical And Biological Research (8731) , Surgical And Medical Instruments And Apparatus (3841)

Profitability

Management Effectiveness

Gross Margin:

58.00

Return on Equity:

11.10

EBIT Margin:

18.90

Return on Capital:

11.10

Profit Margin:

18.90